BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26041837)

  • 1. Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay.
    Jensen TW; Ray T; Wang J; Li X; Naritoku WY; Han B; Bellafiore F; Bagaria SP; Qu A; Cui X; Taylor CR; Ray PS
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26041837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study.
    Ray PS; Bagaria SP; Wang J; Shamonki JM; Ye X; Sim MS; Steen S; Qu Y; Cui X; Giuliano AE
    Ann Surg Oncol; 2011 Dec; 18(13):3839-47. PubMed ID: 21424368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort.
    Johnson J; Choi M; Dadmanesh F; Han B; Qu Y; Yu-Rice Y; Zhang X; Bagaria S; Taylor C; Giuliano AE; Amersi F; Cui X
    Oncotarget; 2016 Nov; 7(46):75729-75738. PubMed ID: 27708239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.
    Jin Y; Han B; Chen J; Wiedemeyer R; Orsulic S; Bose S; Zhang X; Karlan BY; Giuliano AE; Cui Y; Cui X
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4(0 4):S758-66. PubMed ID: 25124473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissues.
    Park S; Wang HY; Kim S; Ahn S; Lee D; Cho Y; Park KH; Jung D; Kim SI; Lee H
    Int J Clin Exp Pathol; 2014; 7(10):6752-9. PubMed ID: 25400755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative real-time polymerase chain reaction is an alternative method for the detection of HER-2 amplification in formalin-fixed paraffin-embedded breast cancer samples.
    Pu T; Guo P; Qiu Y; Chen S; Yang L; Sun L; Ye F; Bu H
    Int J Clin Exp Pathol; 2015; 8(9):10565-74. PubMed ID: 26617766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of BrightGen HR RT-qDx assay to detect nuclear receptors mRNA overexpression in FFPE breast cancer tissue samples for selection of tamoxifen therapy.
    Wang HY; Park S; Kim S; Ahn S; Lee D; Kim S; Jung D; Park KH; Lee H
    Int J Clin Exp Pathol; 2014; 7(9):5792-800. PubMed ID: 25337220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer.
    Chung S; Jin Y; Han B; Qu Y; Gao B; Giuliano AE; Cui X
    Cell Commun Signal; 2017 Jun; 15(1):22. PubMed ID: 28629477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of FOXC1 as a therapeutic target for basal-like breast cancer.
    Mott L; Su K; Pack DW
    Cancer Gene Ther; 2018 May; 25(3-4):84-91. PubMed ID: 29511313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXC1: an emerging marker and therapeutic target for cancer.
    Han B; Bhowmick N; Qu Y; Chung S; Giuliano AE; Cui X
    Oncogene; 2017 Jul; 36(28):3957-3963. PubMed ID: 28288141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.
    Ignatiadis M; Azim HA; Desmedt C; Veys I; Larsimont D; Salgado R; Lyng MB; Viale G; Leyland-Jones B; Giobbie-Hurder A; Kammler R; Dell'Orto P; Rothé F; Laïos I; Ditzel HJ; Regan MM; Piccart M; Michiels S; Sotiriou C
    JAMA Oncol; 2016 Feb; 2(2):217-24. PubMed ID: 26633571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer.
    Ray PS; Wang J; Qu Y; Sim MS; Shamonki J; Bagaria SP; Ye X; Liu B; Elashoff D; Hoon DS; Walter MA; Martens JW; Richardson AL; Giuliano AE; Cui X
    Cancer Res; 2010 May; 70(10):3870-6. PubMed ID: 20406990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-gene diagnostic assay for rapid subclassification of basal like breast cancer with mRNA targeted antisense oligonucleotide capped molecular probe.
    Moitra P; Alafeef M; Dighe K; Pan D
    Biosens Bioelectron; 2022 Jul; 207():114178. PubMed ID: 35316757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
    Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
    Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of a novel RT-qPCR based test for the quantification of HER2 gene expression in breast cancer.
    El Hadi H; Abdellaoui-Maane I; Kottwitz D; El Amrani M; Bouchoutrouch N; Qmichou Z; Karkouri M; ElAttar H; Errihani H; Fernandez PL; Bakri Y; Sefrioui H; Moumen A
    Gene; 2017 Mar; 605():114-122. PubMed ID: 28039034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring novel targets of basal-like breast carcinoma by comparative gene profiling and mechanism analysis.
    Wu YM; Hu W; Wang Y; Wang N; Gao L; Chen ZZ; Zheng WQ
    Breast Cancer Res Treat; 2013 Aug; 141(1):23-32. PubMed ID: 23933801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling.
    Wang J; Ray PS; Sim MS; Zhou XZ; Lu KP; Lee AV; Lin X; Bagaria SP; Giuliano AE; Cui X
    Oncogene; 2012 Nov; 31(45):4798-802. PubMed ID: 22249250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative determination of insulin-like growth factor 1 receptor mRNA in formalin-fixed paraffin-embedded tissues of invasive breast cancer.
    Fu P; Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Zheng S; Iwase H
    Breast Cancer; 2012 Oct; 19(4):321-8. PubMed ID: 21990036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role and the potential regulatory pathways of high expression of forkhead box C1 in promoting tumor growth and metastasis of basal-like breast cancer.
    Zuo HD; Wu Yao W
    J BUON; 2016; 21(4):818-825. PubMed ID: 27685901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Usefulness of a One-Tube Nested Reverse Transcription Quantitative Polymerase Chain Reaction Assay for Evaluating Human Epidermal Growth Factor Receptor 2 mRNA Overexpression in Formalin-Fixed and Paraffin-Embedded Breast Cancer Tissue Samples.
    Wang HY; Ahn S; Park S; Kim S; Lee H
    Pathobiology; 2017; 84(2):57-70. PubMed ID: 27544315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.